Form 4: Avid Bioservices Executive Accelerates Equity Awards Amidst Acquisition

Avid Bioservices' Chief Operations Officer, Richard A. Richieri, accelerated the vesting of performance stock units and sold shares to cover tax obligations in connection with the company's pending acquisition.

Summary

• Richard A. Richieri, Chief Operations Officer of Avid Bioservices, Inc., engaged in transactions involving the company's stock and performance stock units (PSUs).
• These transactions occurred in connection with the planned acquisition of Avid Bioservices by funds managed by GHO Capital Partners LLP and Ampersand Capital Partners.
• The board accelerated the payment of certain equity awards to mitigate adverse tax consequences related to the acquisition.
• On December 25, 2024, Richieri acquired 10,695 shares through the vesting of PSUs and disposed of 48,399 shares.
• On December 26, 2024, Richieri sold 3,843 shares at $12.22 per share to cover tax obligations.
• The accelerated settlement of equity awards was contingent upon Richieri's agreement to repay accelerated compensation amounts under certain conditions.
• A total of 21,389 PSUs were forfeited due to the performance period ending April 30, 2025.

Sentiment

Score: 7

Explanation: The document reflects standard procedures during an acquisition, with no significant negative implications. The forfeiture of some PSUs is a minor negative, but overall the sentiment is neutral to slightly positive.

Positives

• The acceleration of equity awards was intended to mitigate adverse tax consequences for executives, which is a common practice during acquisitions.
• The sale of shares to cover tax obligations is a standard procedure following the vesting of equity awards.

Negatives

• The forfeiture of 21,389 unearned PSUs indicates that certain performance targets were not met for the period ending April 30, 2025.

Risks

• The accelerated vesting of equity awards is contingent on the completion of the acquisition, which is not yet finalized.
• There is a risk that Richieri may have to repay accelerated compensation amounts under certain conditions.

Future Outlook

The transactions are related to the pending acquisition of Avid Bioservices by funds managed by GHO Capital Partners LLP and Ampersand Capital Partners.

Management Comments

• The Board of Directors of the Issuer accelerated the payment of certain equity awards in connection with certain actions to mitigate adverse tax consequences of Section 280G and Section 4999 of the Internal Revenue Code of 1986 (as amended) that could arise in connection with the anticipated transactions under the Merger Agreement.

Industry Context

This type of transaction is common during mergers and acquisitions, where executives often accelerate the vesting of equity awards to mitigate tax implications.

Comparison to Industry Standards

• Accelerated vesting of equity awards during acquisitions is a standard practice across various industries, including biotechnology and pharmaceuticals.
• Similar transactions can be observed in other companies undergoing mergers, such as the recent acquisition of Catalent by Novo Holdings, where executives also had accelerated vesting of stock options and restricted stock units.
• The sale of shares to cover tax obligations is also a common practice, aligning with industry norms for executive compensation.

Stakeholder Impact

• Shareholders may be impacted by the pending acquisition.
• Employees may be impacted by the change in ownership.

Next Steps

• The acquisition of Avid Bioservices is pending.
• The reporting person may be required to repay accelerated compensation amounts under certain conditions.

Key Dates

Keywords

Avid Bioservices, Richard A. Richieri, Performance Stock Units, PSU, Acquisition, Equity Awards, Vesting, Tax Obligations, GHO Capital Partners, Ampersand Capital Partners